Mucinous Cyst Clinical Trials

1 recruiting

Mucinous Cyst Trials at a Glance

6 actively recruiting trials for mucinous cyst are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Phase 1 with 1 trial, with the heaviest enrollment activity in Ningbo, Shanghai, and Jiaxing. Lead sponsors running mucinous cyst studies include Changhai Hospital, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), and Huazhong University of Science and Technology.

Browse mucinous cyst trials by phase

Treatments under study

About Mucinous Cyst Clinical Trials

Looking for clinical trials for Mucinous Cyst? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Mucinous Cyst trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Mucinous Cyst clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting

Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data

Intraductal Papillary Mucinous Neoplasm of PancreasPancreatic Cystic LesionMucinous Cystadenoma of Pancreas+3 more
Huazhong University of Science and Technology500 enrolled2 locationsNCT07463872
Recruiting
Phase 4

Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)

Neuro Endocrine TumoursPDAC - Pancreatic Ductal AdenocarcinomaPancreas Adenocarcinoma+7 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)400 enrolled1 locationNCT07262957
Recruiting

UCSF PANC Cyst Registry

Pancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Neoplasms+5 more
University of California, San Francisco4,000 enrolled1 locationNCT04291651
Recruiting

Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer

Pancreatic CancerPDAC - Pancreatic Ductal AdenocarcinomaIntraductal Papillary Mucinous Neoplasm+2 more
Changhai Hospital400,000 enrolled5 locationsNCT07117045
Recruiting
Phase 1

Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection

Pancreatic CystPancreatic Mucinous Cystic Neoplasm
University of Nebraska15 enrolled1 locationNCT06320990
Recruiting

AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort

Pancreatic CancerPancreatic Ductal AdenocarcinomaIntraductal Papillary Mucinous Neoplasm+2 more
Changhai Hospital5,000 enrolled3 locationsNCT06638866